The government shutdown is drawing backlash from healthcare leaders over its potential to disrupt ACA subsidies, Medicare ...
MedCity News Editor in Chief Arundhati Parmar and Samir Batra, managing partner of Health Innovation Pitch, also discussed ...
Newly launched Pfizer drugs will be priced at parity to prices in comparable developed nations, according to the most-favored ...
At MedCity News’ INVEST Digital Health conference, healthcare experts explored strategies to mitigate automation bias — emphasizing the importance of vendor responsibility, use case-specific ...
Talkspace, a virtual mental health company, announced on Monday that it has acquired Wisdo Health, a platform for social health and peer support. New York City-based Talkspace offers virtual therapy, ...
Healthcare has been moving steadily out of the clinic and into the home. McKinsey estimates that as much as $265 billion in care (nearly a quarter of all Medicare spending) could shift from facilities ...
Boehringer Ingelheim established a presence in idiopathic pulmonary fibrosis years ago with a drug that has become a standard treatment for this serious lung disorder. Now the company has the ...
CertifyOS, a provider data intelligence company, has launched a new platform to help payers manage provider data in their network, the company announced last week. New York City-based CertifyOS serves ...
Editor’s Note: This roundup is meant to highlight some of the most notable funding rounds of the month and is not intended to be comprehensive. Health tech companies made several major funding ...
A subcutaneously injected version of Merck cancer immunotherapy Keytruda is now FDA approved, a regulatory decision that gives patients a less burdensome dosing option and provides the pharmaceutical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results